NCT01895829 2021-09-21Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRIM.D. Anderson Cancer CenterPhase EARLY_PHASE1 Terminated7 enrolled
NCT01770353 2019-11-27MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to TreatmentIpsenPhase 1 Completed45 enrolled 33 charts